CLINICAL_TRIALS
trial_result
· 2012-07-03
Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis [Phase 2]
Summary
Phase 2 study evaluating inhaled ciprofloxacin for safety and efficacy in cystic fibrosis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2012-07-03